News : Kaprolac

Moberg Derma AB (publ.) has entered into a distribution agreement with Gebro Pharma AG S.A. for Emtrix® – for treatment of discolored and deformed nails resulting from fungal infection  (onychomycosis) or psoriasis, and Kaprolac® – for problems with dry and flaky skin and. Under the agreement, Gebro is granted exclusive rights to market and sell Emtrix®, Kaprolac® Dandruff Shampoo and Kaprolac® Scalp Solution in...

Moberg Derma AB and MedPharm Ltd today announce a license and distribution agreement for the development, marketing and sales of new dermatology products that will combine Moberg Derma’s Kaprolac® platform with MedPharm’s MedSpray™ technology. According to the agreement, MedPharm will be eligible for royalty payments.
Moberg Derma obtains the exclusive rights to worldwide manufacturing, distribution and sales...